Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 1/20 | 0.55 |
| ▸ | SLC5A2 | P31639 | 8/20 | 0.49 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL995764 | 1.00 | PYGL (0.55) | PYGLSLC5A2CD209 | |
| SCHEMBL8766883 | 0.88 | EPHX1 (0.50) | PYGLCD209 | |
| SCHEMBL25605620 | 0.86 | PYGL (0.46) | PYGLSLC5A2CD209 | |
| SCHEMBL3759096 | 0.86 | PYGL (0.52) | PYGLSLC5A2CD209 | |
| SCHEMBL23797741 | 0.83 | LGALS3 (0.47) | PYGLSLC5A2CD209 | |
| SCHEMBL23547663 | 0.83 | LGALS3 (0.47) | PYGLSLC5A2CD209 | |
| SCHEMBL2917657 | 0.78 | SLC5A2 (0.57) | PYGLSLC5A2 | |
| SCHEMBL27843034 | 0.78 | EPHX1 (0.44) | PYGLCD209 | |
| SCHEMBL440403 | 0.77 | SLC5A2 (0.59) | PYGLSLC5A2 | |
| SCHEMBL6542524 | 0.77 | SLC5A2 (0.59) | PYGLSLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0799313-A2 | METHOD AND REAGENT FOR TREATMENT OF ARTHRITIC CONDITIONS, INDUCTION OF GRAFT TOLERANCE AND REVERSAL OF IMMUNE RESPONSES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1997-10-08 | — | — | EP | disclosed |
| US-5672501-A | Base-modified enzymatic nucleic acid | RIBOZYME PHARMACEUTICALS, INC. (US) | 1997-09-30 | — | — | US | disclosed |
| EP-0416817-B1 | Amplification processes | ZENECA LTD (GB) | 1996-10-16 | — | — | EP | disclosed |
| US-5536537-A | SILICONE EMULSIONS | TOSHIBA SILICONE CO., LTD (JP) | 1996-07-16 | — | — | US | disclosed |
| WO-1996018736-A2 | METHOD AND REAGENT FOR TREATMENT OF ARTHRITIC CONDITIONS, INDUCTION OF GRAFT TOLERANCE AND REVERSAL OF IMMUNE RESPONSES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| US-5525494-A | Amplification processes | ZENECA LIMITED (GB) | 1996-06-11 | — | — | US | disclosed |
| EP-0416817-A2 | Amplification processes | ZENECA LIMITED (GB) | 1991-03-13 | — | — | EP | disclosed |